Key result
HF management in infants with CHD lacks sufficient data, demanding expanded prevention and treatment strategies.
Why the study?
Although surgical management of CHD has advanced and adult HF management is largely evidence-based, data on HF management approaches in infants are limited.
Highlights the critical need for more evidence-based approaches to managing heart failure in infants with congenital heart disease.
Evidence gaps warrant cautious HF management in infants with CHD; leaves open optimal strategies for dedicated trials.
Tremendous advances have been made in the last 5 decades in the surgical management of congenital heart disease (CHD). Most infants affected by clinically significant CHD are at risk for developing heart failure (HF). Adult HF management is mostly evidence-based and our knowledge in this field has expanded significantly in the past decade. However, data on management approaches for HF in infants are limited. The indications and implications for various medications and interventions in patients with HF secondary to CHD are an upcoming area of interest. It is critical that we expand our ability to prevent, detect, and manage HF in the pediatric population.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2021) conducted a review in Heart failure in infants with congenital heart disease. Loop Diuretics was evaluated. Management approaches for heart failure in infants with congenital heart disease lack sufficient data, highlighting a critical need to expand prevention, detection, and management strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: